Latest filing published 01 Apr 2026 for Starling Oncology, Inc..
Insider track record
No signal scores available.
Kristin England: trading record in brief
Kristin England discloses dealings in Starling Oncology, Inc. to SEC (Form 4). Over a trading history stretching from 22 July 2025 to 27 March 2026, the count stands at 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 1 April 2026, reports a share grant in Starling Oncology, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kristin England
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 55,743 shares0Common StockSEC:0001079973-26-000447:0
- 98,037 shares0Common StockSEC:0000935836-25-000470:0
2 of 2 declarations
